PepGen
Neurology & CNS Therapeutics · Rare Disease Therapeutics

PepGen news and milestones

PepGen: 9 headlines on record, 0 headlines in the last 90 days. Its story counts 2 milestones.

Data updated Nov 16, 2026 · Back to the company report
9Headlines
0In 90 days
2Milestones

Headlines

Aug 72026
Press release · The Globe and Mail
Detailed price information for Pepgen Inc (PEPG-Q) from The Globe and Mail including charting and trades.
May 202026
News · YahooFinance
PepGen (PEPG) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising…
Sep 26, 20252025
News · YahooFinance
BOSTON,, September 26, 2025--PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company developing the next generation of oligonucleotide therapies with the goal of trans…
Aug 9, 20252025
Press release · PRNewswire
/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against PepGen Inc. ("PepGen" or the "Company")...
Aug 3, 20252025
Press release · PRNewswire
/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against PepGen Inc. ("PepGen" or the "Company")...
Feb 24, 20252025
News · MedCity News
PepGen is one of several companies vying to bring to market the first treatment for the rare muscle disorder myotonic dystrophy type 1, or DM1. Preliminary Phase 1 data indicate…
May 20, 20242024
News · seekingalpha.com
Sources: the outlets named on each headline, each story once

Milestones

Each milestone is dated by its source: registers, filings, the press

How to cite

PepGen, News. Alion, Nov 16, 2026. https://alion.io/company/pepgen/news

.json · .md · CC BY-SA 4.0